Fujitsu develops multi-AI agent collaboration technology to optimise pharma supply chains

December 1, 2025 | Monday | News

Securely connecting AI agents across multiple companies for rapid response to changing circumstances

image credit- shutterstock

image credit- shutterstock

Japan's Fujitsu Limited has announced the development of a multi-AI agent collaboration technology that enables secure collaboration and swift response to changing circumstances among AI agents from different companies and vendors within a supply chain.

Leveraging this technology, Fujitsu will start field trials in January 2026 to optimise the supply chain of Rohto Pharmaceutical Co. in collaboration with the Institute of Science Tokyo (Science Tokyo). This innovation not only streamlines daily supply chain operations but also facilitates rapid recovery during emergencies like sudden demand shifts or disasters.

In addition, Fujitsu will contribute to the new industry promotion activities of the Council on Competitiveness-Nippon (COCN) to realise AI spaces that enable secure data and AI collaboration across different companies, aiming to strengthen the competitiveness of Japanese industry through agentic AI.

Fujitsu will continue to advance demonstration and technological enhancement with Science Tokyo and Rohto Pharmaceutical, aiming for expansion into diverse industries, including manufacturing. Fujitsu will also develop technology for broader and more complex supply chains, targeting provision through its Uvance business model's Dynamic Supply Chain services by the end of fiscal 2026. This will bring a new perspective to corporate supply chain strategies, enhancing resilience, and enabling sustainable business operations.

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account